(Press-News.org)
New research from the University of Vermont reveals exposure to smoke from Canadian wildfires in the summer of 2023 led to worsening asthma symptoms in children in Vermont and upstate New York.
The study, published today [12/11] in the journal Environmental Health, is the first to examine the relationship between wildfire smoke and asthma in the Northeast—which in recent years has seen a marked increase in poor air quality days due to wildfires.
“In 2023 when we couldn’t see New York across the lake, a lot of Vermonters began to worry about wildfire smoke,” says Anna Maassel, a Ph.D. candidate at the Rubenstein School of Environment and Natural Resources, graduate fellow at the Gund Institute for Environment, and lead author of the paper. “A lot of people think of Vermont as a relatively safe place to live when it comes to climate change, but we found that smoke coming from hundreds of miles away affected children here.”
Wildfire smoke contains tiny particles known as PM2.5, along with other toxic pollutants that can damage the lungs and worsen respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Nationwide, 6.5% of children and 8% of adults have asthma. Vermont’s rates are higher with 7% of children and 11% of adults diagnosed with the disease.
To assess if wildfire smoke from 2023 affected children in the area, the researchers accessed electronic health records for about 900 youth, ages 3-21, who were receiving treatment for asthma in Vermont and upstate New York through University of Vermont Health.
The team analyzed three different clinical measures that assess how well-controlled a patient’s asthma is for the summers of 2022-2024. Then, they overlaid air quality data onto the region and estimated smoke exposure within each zip code.
Compared with the relatively smoke-free summer of 2022, children’s asthma was significantly less controlled during the smoke-heavy summer of 2023, when plumes from Quebec blanketed the region.
“In the summer of 2023, my pediatric pulmonology team received a high volume of phone calls from concerned parents saying, ‘My child is having trouble with asthma symptoms,” says Dr. Keith Robinson, a pediatric lung doctor at Golisano Children’s Hospital at UVM and co-author of the paper.
The researchers didn’t find the same signal when they compared 2023 with 2024, which was surprising, and the team hopes future research could shed light on why. Still, Robinson says it’s clear that wildfire smoke is affecting Vermont’s youth.
“I think our findings suggest that there is potential for wildfire smoke, even hundreds of miles away, to impact a child's health,” he says.
Across the country, pollution from wildfire smoke is increasing. A study published earlier this year estimated climate change is projected to exacerbate the problem, leading to roughly 70,000 premature deaths each year by 2050. Without action, wildfire smoke could become one of the country’s worst climate disasters, the authors write.
Robinson says there are steps clinicians can take to help families reduce exposure to wildfire smoke, including closing windows, avoiding outdoor activities and using air purifiers when air quality is poor.
“Clinicians need to make sure that parents and patients understand how to check for air quality, especially when there are wildfires in the area,” he says. “We also need to make sure that patients and families who do not have the means to mitigate the effects of wildfire smoke have support from public health agencies.”
The study was funded by UVM’s Planetary Health Initiative and brought researchers together from across UVM, the Robert Larner M.D. College of Medicine and UVM Health.
“When you’re able to work with researchers that have a different area of expertise, it brings the impact to another level. Personally, I learned a lot from my teammates about climate change and environmental health. This project demonstrates the impact of collaboration across UVM departments,” Robinson said.
The research also reflects the university’s commitment to Vermont.
“This study is another example of how UVM researchers can engage with our state and our region to connect the dots between climate change and human health,” said Taylor Ricketts, director of UVM’s Gund Institute for Environment and co-author of the paper. “Understanding emerging threats to children’s health is a first step toward anticipating and reducing them.”
The research team also included: Paige Brochu, a research assistant professor in the Rubenstein School, director of UVM’s Spatial Analysis Laboratory and a Gund Institute affiliate; Valerie Harder, with the Vermont Child Health Improvement Program and a professor in the Department of Pediatrics at the Larner College of Medicine; and Dr. Stephen Teach, a pediatric emergency medicine physician at University of Vermont Health and the Larner College of Medicine.
END
The old proverb “it takes a village to raise a child” also applies to preventing youth suicide, according to UBC Okanagan researchers who found that community support is essential.
In Canada, suicide is the fourth leading cause of death among children under 14 and the second for youth and young adults between 15 and 34 years old. The UBCO Faculty of Health and Social Development researchers say governments, schools and community agencies need to rethink how youth suicide prevention efforts are designed.
And work together on the issue.
“Suicide among young people is a major public health issue and is among the leading causes of death among children ...
Words reflecting diversity language have appeared less frequently in grants awarded by the National Institutes of Health (NIH) since the 2024 US presidential election, with a 25% relative decrease between January 2024 and June 2025, finds a study in the Christmas issue of The BMJ.
News reports have indicated that US federal agencies have recently limited or discouraged use of words related to diversity, health inequities, and other scientific subjects commanding political attention in NIH research grants.
News reports also suggest that researchers may be modifying their language or research topics to align with federal ...
AI chatbot systems, such as ChatGPT, Claude, and Copilot, are used increasingly as confidants of choice, but turning to AI chatbots for companionship and emotional support is a cause for concern, especially in younger people, say experts in the Christmas issue of The BMJ.
They warn that “we might be witnessing a generation learning to form emotional bonds with entities that lack capacities for human-like empathy, care, and relational attunement” and say evidence based strategies for reducing ...
Authors in biomedical journals frequently describe cited evidence as “recent,” yet the actual age of the references behind these phrases has rarely been measured.
To measure how recent the "recent" studies really are, researchers based in Spain analysed 1000 biomedical articles containing 20 predefined “recent” expressions directly linked to a citation.
Their findings in the Christmas issue of The BMJ show that the citation lag ranged from 0 to 37 years, with a median of 4 years and a mean of 5.5 years.
The most frequent ...
A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhoea, according to a phase 3 clinical trial published in The Lancet. The study found that one dose of zoliflodacin was as effective as the current standard treatment, which combines two antibiotics: an injection of ceftriaxone followed by an oral dose of azithromycin.
Gonorrhoea is one of the most common sexually transmitted infections, affecting over 82 million people globally each year. However, it is increasingly difficult to treat as the bacteria that cause ...
At five years, 90.9% of proton patients were alive compared to 81% with traditional radiation
Proton therapy also showed benefits in quality of life, such as less feeding tube dependence, less difficulty swallowing, less dry mouth, and higher immune cell counts
Study represents the largest randomized Phase III trial comparing proton to traditional radiation with photons for oropharyngeal cancer patients
HOUSTON, DECEMBER 11, 2025 ― A new study published today in The Lancet showed a significant ...
A blood biomarker yet to be used in cardiac arrest care can give a clearer picture of the extent of brain damage after a cardiac arrest. This has been shown in a large international multicentre study led by researchers at Lund University that has been published in The Lancet Respiratory Medicine. Worldwide, around four million people each year suffer a sudden cardiac arrest
“This will transform care for these patients,” says researcher Marion Moseby Knappe.
Key facts about the study: clinical prospective multicentre study // 819 patients // out-of- hospital cardiac arrest //
A simple blood test that can very accurately predict the chance of survival with good recovery ...
A new UBC Okanagan study found that people who microdose psychedelics feel better on the days they take them—but those boosts don’t seem to last.
This suggests, says Dr. Michelle St. Pierre, that perceived benefits may be acute rather than long lasting.
Dr. St. Pierre is a post-doctoral psychology researcher with UBCO’s Irving K. Barber Faculty of Arts and Sciences. She recently published a study in Psychopharmacology that tracks the daily experiences of people who microdose with psychedelics.
Microdosing involves ingesting small amounts of a psychedelic substance, commonly psilocybin mushrooms or lysergic acid diethylamide (LSD).
“Most ...
A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting treatment benefits in patients with hormone receptor-positive (HR+) metastatic breast cancer that has spread primarily or exclusively to the bones. These patients make up a large portion of individuals who are living with advanced breast cancer—yet are routinely excluded from clinical trials that rely on standard imaging-based assessments (i.e., RECIST 1.1). The study demonstrated that metabolic change assessed by FDG-PET/CT accurately predicted progression-free ...
December 11, 2025, CLEVELAND: Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
The study team found that the investigational vaccine produced an immune response in the majority (74%) of all participants and was safe and well tolerated. They determined the maximum tolerated dose and described that side effects primarily consisted of mild skin inflammation at the injection site. The findings, which will inform the ...